**About the Editor**

#### **Fabrizio Bianchi**

Fabrizio Bianchi, M.Sc. in Biological Sciences, Ph.D. in Molecular and Biological Sciences, is Head of the Cancer Biomarkers Unit at the Research Hospital (IRCCS) Fondazione Casa Sollievo della Sofferenza. He is expert in the field of cancer transcriptomics and cancer biomarkers. Dr. Bianchi pioneered the identification of serum circulating microRNAs for lung cancer early detection. He worked as research fellow at the FIRC Institute for Molecular Oncology (Milan, Italy), and at the Program of Molecular Medicine of the European Institute of Oncology (Milan, Italy). He has been a visiting scientist at the Nuffield Department of Clinical and Laboratory Sciences at University of Oxford (England, UK). Dr. Bianchi is member of the American Association for Cancer Research (AACR), the European Association for Cancer Research (EACR), and member of the steering committee of the Italian Cancer Society (SIC).
